learn more about working at cbo and check out the agency’s career opportunities
Medicare publications from cbo
Issues in Designing a Prescription Drug Benefit for Medicare
reportOctober 30, 2002Letter to the Honorable W. J. "Billy" Tauzin regarding H.R. 4954, the Medicare Modernization and Prescription Drug Act of 2002
reportSeptember 24, 2002Testimony on Disease Management in Medicare: Data Analysis and Benefit Design Issues
reportSeptember 19, 2002Letter to the Honorable William "Bill" M. Thomas regarding CBO's cost estimate for H.R. 4954, the Medicare Modernization and Prescription Drug Act of 2002
reportJuly 27, 2002Preliminary cost estimate of S. 812 as Modified by the Edwards-Collins Amendment
reportJuly 18, 2002Preliminary Cost Estimates of the Effects on Direct Spending of Establishing a Prescription Drug Benefit in Medicare
reportApril 8, 2002Testimony on Projections of Medicare and Prescription Drug Spending
reportMarch 7, 2002Letter to the Honorable Michael Bilirakis regarding CBO's estimate of the costs of a prescription drug benefit in Medicare
reportAugust 10, 2001Letter to the Honorable Max Baucus regarding updated estimates of the direct spending effects of four proposals from the 106th Congress for a prescription drug benefit in Medicare (Tables 1 and 5 corrected 08/10/2001)
reportJune 11, 2001Testimony on Medicare Reform: Providing Prescription Drug Coverage for Seniors
reportMay 16, 2001Testimony on Laying the Groundwork for a Medicare Prescription Drug Benefit
reportMarch 27, 2001Testimony on Prescription Drugs and Medicare Financing
reportMarch 22, 2001Letter to the Honorable Frank R. Lautenberg regarding the assumptions underlying CBO's estimates of proposals for a Medicare prescription drug benefit
reportSeptember 1, 2000Testimony on a CBO Analysis of the Administration's Prescription Drug Proposal
reportMay 11, 2000How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry
reportJuly 1, 1998How the Medicaid Rebate on Prescription Drugs Affects Pricing in the Pharmaceutical Industry
reportJanuary 1, 1996